Right-to-left shunts in lowlanders with COPD traveling to altitude - A randomized controlled trial with dexamethasone.
Right-to-left shunts (RLS) are prevalent in patients with chronic obstructive pulmonary disease (COPD) and might exaggerate oxygen desaturation, especially at altitude. To study the prevalence of RLS in patients with COPD traveling to altitude and the effect of preventive dexamethasone. Lowlanders with COPD, GOLD 1-2, oxygen saturation (SpO2) >92%, were randomized to dexamethasone (4 mg, bid) or placebo, starting 24 h before ascent from 760 m and while staying at 3,100 m for 48 h. Saline contrast echocardiography was performed at 760 m and after the first night at altitude. Of 87 patients (81 men, mean ±SD age 57 ±9 y, FEV1 89 ±22 % pred, SpO2 95 ±2 %) 39 were assigned to placebo, 48 to dexamethasone. In the placebo group, 19 patients (49%) had RLS, of which 13 intracardiac. In the dexamethasone group 23 patients (48%) had RLS, of which 11 intracardiac (p=1.0 vs. dexamethasone). 11 patients receiving placebo and 13 dexamethasone developed new RLS at altitude (p=0.011 both changes, p=0.411 between groups). RLS prevalence at 3,100 m was 30 (77%) in the placebo and 36 (75%) in the dexamethasone group (p=ns). Development of RLS at altitude could be predicted at lowland by a higher resting pulmonary artery pressure, a lower paO2 and a greater oxygen desaturation during exercise but not by treatment allocation. Almost half of lowlanders with COPD revealed RLS near sea level and this proportion significantly increased to about 3/4 when traveling to 3,100 m irrespective of dexamethasone prophylaxis.